Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Clinical applications of precision oncology require accurate tests that can distinguish true cancer-specific mutations from errors introduced at each step of next-generation sequencing (NGS). To date, no bulk sequencing study has addressed the effects of cross-site reproducibility, nor the biological, technical and computational factors that influence variant identification. Here we report a systematic interrogation of somatic mutations in paired tumor–normal cell lines to identify factors affecting detection reproducibility and accuracy at six different centers. Using whole-genome sequencing (WGS) and whole-exome sequencing (WES), we evaluated the reproducibility of different sample types with varying input amount and tumor purity, and multiple library construction protocols, followed by processing with nine bioinformatics pipelines. We found that read coverage and callers affected both WGS and WES reproducibility, but WES performance was influenced by insert fragment size, genomic copy content and the global imbalance score (GIV; G > T/C > A). Finally, taking into account library preparation protocol, tumor content, read coverage and bioinformatics processes concomitantly, we recommend actionable practices to improve the reproducibility and accuracy of NGS experiments for cancer mutation detection. Recommendations are given on optimal read coverage and selection of calling algorithm to maximize the reproducibility of cancer mutation detection in whole-genome or whole-exome sequencing.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
MultiQC: summarize analysis results for multiple tools and samples in a single report
Ewels, P., Magnusson, M., Lundin, S., & Käller, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw354 · Cited by 10,143
Kraken: ultrafast metagenomic sequence classification using exact alignments
Wood, D. E., & Salzberg, S. L. (2014) · Genome Biology · doi:10.1186/gb-2014-15-3-r46 · Cited by 4,521
Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
Chalmers, Z. R., Connelly, C. F., Fabrizio, D., Gay, L., Ali, S. M., Ennis, R., Schrock, A., Campbell, B., Shlien, A., Chmielecki, J., et al. (2017) · Genome Medicine · doi:10.1186/s13073-017-0424-2 · Cited by 3,519
Raise standards for preclinical cancer research
Begley, C. G., & Ellis, L. M. (2012) · Nature · doi:10.1038/483531a · Cited by 2,979
Qualimap 2: advanced multi-sample quality control for high-throughput sequencing data
Okonechnikov, K., Conesa, A., & García-Alcalde, F. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btv566 · Cited by 2,145
Extensive sequencing of seven human genomes to characterize benchmark reference materials
Zook, J. M., Catoe, D., McDaniel, J., Vang, L., Spies, N., Sidow, A., Weng, Z., Liu, Y., Mason, C. E., Alexander, N., et al. (2016) · Scientific Data · doi:10.1038/sdata.2016.25 · Cited by 811
Self-citationWhat is missing from descriptions of treatment in trials and reviews?
Glasziou, P., Meats, E., Heneghan, C., & Shepperd, S. (2008) · BMJ · doi:10.1136/bmj.39590.732037.47 · Cited by 614
Vasilevsky, N. A., Brush, M. H., Paddock, H., Ponting, L., Tripathy, S. J., LaRocca, G. M., & Haendel, M. A. (2013) · PeerJ · doi:10.7717/peerj.148 · Cited by 271
A multicenter study benchmarking single-cell RNA sequencing technologies using reference samples
Chen, W., Zhao, Y., Chen, X., Yang, Z., Xu, X., Bi, Y., Chen, V., Li, J., Choi, H., Ernest, B., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00748-9 · Cited by 114
Self-citation
Cited by
Swanson, K., Wu, E., Zhang, A., Alizadeh, A. A., & Zou, J. (2023) · Cell · doi:10.1016/j.cell.2023.01.035 · Cited by 597
“65 This tradeoff is further amplified when creating molecular datasets for ML applications.”
BackgroundA multicenter study benchmarking single-cell RNA sequencing technologies using reference samples
Chen, W., Zhao, Y., Chen, X., Yang, Z., Xu, X., Bi, Y., Chen, V., Li, J., Choi, H., Ernest, B., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00748-9 · Cited by 114
Self-citationKinnersley, B., Sud, A., Everall, A., Cornish, A. J., Chubb, D., Culliford, R., Gruber, A. J., Lärkeryd, A., Mitsopoulos, C., Wedge, D., et al. (2024) · Nature Genetics · doi:10.1038/s41588-024-01785-9 · Cited by 73
Sahraeian, S. M. E., Fang, L. T., Karagiannis, K., Moos, M., Smith, S., Santana-Quintero, L., Xiao, C., Colgan, M., Hong, H., Mohiyuddin, M., et al. (2022) · Genome biology · doi:10.1186/s13059-021-02592-9 · Cited by 27
“…Working Group in the FDA-led Sequencing Quality Control Phase II (SEQC2) consortium characterized matched tumor-normal reference samples: a human triple-negative breast cancer cell line (HCC1395) and a normal cell line derived from B lymphocytes (HCC1395BL) [2, 3], both from the same donor.”
BackgroundMethodInfluentialSelf-citation
Metadata
- Authors
- Xiao, W., Ren, L., Chen, Z., Fang, L. T., Zhao, Y., Lack, J., Guan, M., Zhu, B., Jaeger, E., Kerrigan, L., Blomquist, T. M., Hung, T., Sultan, M., Idler, K., Lu, C., Scherer, A., Kusko, R., Moos, M., Xiao, C., Sherry, S. T., Abaan, O. D., Chen, W., Chen, X., Nordlund, J., Liljedahl, U., Maestro, R., Polano, M., Drabek, J., Vojta, P., Kõks, S., Reimann, E., Madala, B. S., Mercer, T., Miller, C., Jacob, H., Truong, T., Moshrefi, A., Natarajan, A., Granat, A., Schroth, G. P., Kalamegham, R., Peters, E., Petitjean, V., Walton, A., Shen, T.-W., Talsania, K., Vera, C. J., Langenbach, K., de Mars, M., Hipp, J. A., Willey, J. C., Wang, J., Shetty, J., Kriga, Y., Raziuddin, A., Tran, B., Zheng, Y., Yu, Y., Cam, M., Jailwala, P., Nguyen, C., Meerzaman, D., Chen, Q., Yan, C., Ernest, B., Mehra, U., Jensen, R. V., Jones, W., Li, J.-L., Papas, B. N., Pirooznia, M., Chen, Y.-C., Seifuddin, F., Li, Z., Liu, X., Resch, W., Wang, J., Wu, L., Yavas, G., Miles, C., Ning, B., Tong, W., Mason, C. E., Donaldson, E., Lababidi, S., Staudt, L. M., Tezak, Z., Hong, H., Wang, C., & Shi, L.
- Venue
- Nature Biotechnology
- Published
- 2021-09
- Volume
- 39
- Issue
- 9
- Pages
- 1141-1150
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W3194965953
- Cited by
- 190
- References
- 10
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. https://app.cochat.ai/papers/10.1038/s41587-021-00994-5
- The paper
- Xiao, W., Ren, L., Chen, Z., Fang, L. T., Zhao, Y., Lack, J., Guan, M., Zhu, B., Jaeger, E., Kerrigan, L., Blomquist, T. M., Hung, T., Sultan, M., Idler, K., Lu, C., Scherer, A., Kusko, R., Moos, M., Xiao, C., . . . Shi, L. (2021). Toward best practice in cancer mutation detection with whole-genome and whole-exome sequencing. Nature Biotechnology. https://doi.org/10.1038/s41587-021-00994-5
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.